SIGLEC1 and psoriasis: To investigate the role of CD169+ macrophages in psoriasis, we utilized CD169-DTR mice, which express the knocked-in human diphtheria toxin receptor (DTR) under the regulatory control of the CD169 promoter, enabling selective depletion of CD169+ macrophages after administration of diphtheria toxin (DT) to the mice.